In exogenous research applications, the synthetic BPC-157 fragment has been evaluated across tissue types spanning the entire musculoskeletal system, gastrointestinal tract, liver, pancreas, cardiovascular system, and central nervous system producing consistently positive results across an unusually wide range of injury and dysfunction models
Effectiveness At the maximum dose in initial clinical studies, 70% of adult participants who took Qysmia lost at least 5% of their body weight in one year
The pharmacokinetic properties of glucagon-like peptide-1 receptor agonists and their mode and mechanism of action in patients with type 2 diabetes
These are measurements cold, not pumped
Because of their opposite functions on food intake and metabolic targets (Engelstoft & Schwartz, 2016), both hormones have gained traction as pharmacological targets for treatment of metabolic (i.e., obesity and type 2 diabetes (T2D)) and eating disorders (Atalayer et al., 2013
